This HTML5 document contains 210 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n12http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35050505
rdf:type
wikibase:Item
schema:description
2011年论文 научни чланак artykuł naukowy scienca artikolo wissenschaftlicher Artikel scientific article bilimsel makale ২০১১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2011年論文 مقالة علمية 2011年論文 tudományos cikk سائنسی مضمون teaduslik artikkel artigo científico (publicado na 2011) artigo científico vedecký článok artículu científicu espublizáu en 2011 2011年论文 บทความทางวิทยาศาสตร์ naučni članak articolo scientifico tieteellinen artikkeli mokslinis straipsnis научная статья مقالهٔ علمی artigo científico (publicado na 2011) 2011年論文 artikull shkencor articol științific 2011年论文 article científic 2011年论文 2011 nî lūn-bûn מאמר מדעי vědecký článek 2011年の論文 vetenskaplig artikel 2011년 논문 2011 թուականի Մայիսին հրատարակուած գիտական յօդուած article scientifique (publié 2011) videnskabelig artikel (udgivet 2011) 2011年論文 2011年论文 artículo científico publicado en 2011 vitenskapelig artikkel სამეცნიერო სტატია научна статия мақолаи илмӣ article scientific наукова стаття, опублікована в травні 2011 wetenschappelijk artikel 2011 թվականի մայիսին հրատարակված գիտական հոդված 2011年论文 vitskapeleg artikkel научни чланак bài báo khoa học επιστημονικό άρθρο 2011年論文 artikulong pang-agham мақолаи илмӣ
p:P577
wds:Q35050505-F3AFE18C-6126-4010-992B-570B23073189
wdt:P577
2011-05-03T00:00:00Z
p:P407
wds:Q35050505-14DF52BD-F5A5-40CB-8F13-3AED6AC56FA8
wdt:P407
wd:Q1860
p:P2860
wds:Q35050505-906B1057-DED3-4415-BABB-FB6A5F257B77 wds:Q35050505-A1D0F662-2B7E-46C9-BFD2-1B321922FB51 wds:Q35050505-89CFA655-BDDB-484F-9B80-7948C2814013 wds:Q35050505-8A0531B5-39A6-43A6-B7C8-29AEB8CF2392 wds:Q35050505-8CDA0690-2200-490F-AFB5-8031C583536A wds:Q35050505-8E1566FE-06C6-414A-A30A-37AABBC19BDB wds:Q35050505-8736B671-1940-4EF7-ABC8-52F09AAA4773 wds:Q35050505-8999387F-A81B-415B-A57D-5974D0D22C16 wds:Q35050505-6331ECEB-259E-47BB-9C5E-3EF01466AB34 wds:Q35050505-6D9267E5-DDDC-4E81-8E16-78C57F86D43C wds:Q35050505-79596E34-8D7F-40EA-B6FC-A00D3E8AD016 wds:Q35050505-79660047-A260-4A7B-AE81-2E9477B608CB wds:Q35050505-52C38A20-1D6D-44DB-90AE-96B22C414F02 wds:Q35050505-5AD617DD-DBA4-431B-9BFA-65460794E00B wds:Q35050505-61CED9D6-0724-403A-919E-5FD123AB729A wds:Q35050505-4C9C6DF4-BCB0-41B0-9E8D-E0D02F0AEFA3 wds:Q35050505-3D0C33E1-9ECC-4C5B-BC0F-EC843BFD26DB wds:Q35050505-3D713786-D431-4BD9-8701-85AC2555BD4C wds:Q35050505-2A4A4193-5D1A-4CCA-A4C3-71559E019B7B wds:Q35050505-2AE4E79B-38BB-4244-82CA-FBEC084C58E5 wds:Q35050505-34B0EDC6-978D-4B68-AF20-65B71D144B2A wds:Q35050505-1B657CC6-25F8-48EF-B69B-DDB4221B41DF wds:Q35050505-1E46213D-7633-42A1-B308-6659AF4CA01F wds:Q35050505-2541BE48-6480-47ED-A02A-7426D9AE494A wds:Q35050505-09BA6381-148A-4920-823B-3BD00D582E83 wds:Q35050505-13415C3D-283E-454C-9744-F18B841FB9DE wds:Q35050505-16B85263-E93D-4A13-9F8A-0F7B9039A8E4 wds:Q35050505-01D0ACF7-E8CC-402C-A1DA-D806FFC5B080 wds:Q35050505-046C21E4-B405-41CF-9438-476D5C9158BA wds:Q35050505-085AAC50-08E4-4E0C-BC52-984318C8F086 wds:Q35050505-F8FAD7BF-0D90-413E-8DD1-7E1C378339C2 wds:Q35050505-EBE79EB3-554F-4C34-9B06-0E665C4D921F wds:Q35050505-EF94F7D1-C56E-4D5F-854A-B2F8D07FE1F2 wds:Q35050505-F1FDC40F-34B4-41B3-B4DF-F9D5D0EBF750 wds:Q35050505-D0884CAF-39E6-4749-A488-FCB9749ABE92 wds:Q35050505-E9236A23-AA82-4073-A34C-DAE32F86C163 wds:Q35050505-C59FD3F7-B626-405E-A9E6-864E48889166 wds:Q35050505-C692F5B1-60EA-41A9-94A4-8679AB7EC066 wds:Q35050505-CC461818-AF3B-4381-926C-D92815AB3285 wds:Q35050505-D0806B78-B437-4EB7-980E-AED4D7E5E797 wds:Q35050505-BC1EE1CA-EABB-4984-95B9-B67E0273F424 wds:Q35050505-BC36EAC5-1384-4DDD-937B-F6D6CFADCB77 wds:Q35050505-BFA276B5-97B2-4DD7-A99A-690B3E5B192E wds:Q35050505-B5D2074B-D434-4F2D-BF00-ADFD9CD03241 wds:Q35050505-B8ECBC01-58EC-4832-A62B-9F0BE75DEFB9 wds:Q35050505-A4ADFB9F-C92F-48C2-B717-8484DE461C6C wds:Q35050505-A6BEF8F2-6A0C-42BB-881B-310F4B0366AB wds:Q35050505-AC4EA302-14BD-4D0B-8EC0-CCBD8FE2FAF4 wds:Q35050505-ACF0056C-1AB4-4F6E-B766-FFB64AEA4719
wdt:P2860
wd:Q21145847 wd:Q40821386 wd:Q40278205 wd:Q35612494 wd:Q36743436 wd:Q34116818 wd:Q25938999 wd:Q40891727 wd:Q45928831 wd:Q53587646 wd:Q71090495 wd:Q79803065 wd:Q73404189 wd:Q24310871 wd:Q81548329 wd:Q42593305 wd:Q79362790 wd:Q46321173 wd:Q77620091 wd:Q40964785 wd:Q29614563 wd:Q46104296 wd:Q51803667 wd:Q47982760 wd:Q33943864 wd:Q36902840 wd:Q43211411 wd:Q39991755 wd:Q39719063 wd:Q39827828 wd:Q24632296 wd:Q31789323 wd:Q34627942 wd:Q37300871 wd:Q40456758 wd:Q43648029 wd:Q40602141 wd:Q45408162 wd:Q22255634 wd:Q36484099 wd:Q37630203 wd:Q45122027 wd:Q28277365 wd:Q33855204 wd:Q44280916 wd:Q43199035 wd:Q33761278 wd:Q38492407 wd:Q73311795
p:P2093
wds:Q35050505-5C6D9775-F8A3-450A-8E85-2CF800CAAFB0 wds:Q35050505-31E03017-A634-41E8-BA6B-F469C51B8977 wds:Q35050505-C1A532D4-A949-4095-B8DE-4C0792AA130F wds:Q35050505-B645411E-93EB-458B-816C-AD3505139EF8 wds:Q35050505-AF87CD2D-653E-4E33-BFC4-20EAD4AFCFE6 wds:Q35050505-F24C32A2-EE31-4E0C-9F17-3FF6364BF754 wds:Q35050505-D2EFB242-1EF3-4411-B833-CB1D72CA56A5
wdt:P2093
Timothy Back Sylvie Guichard Qun Jiang Tim Chan Robert H Wiltrout Jonathan M Weiss John R Ortaldo
rdfs:label
mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment
skos:prefLabel
mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment
schema:name
mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment
p:P1476
wds:Q35050505-40A62DF7-E8FE-4C72-9492-ABA0BD2A1304
wdt:P1476
mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity of an agonist CD40 antibody in cancer treatment
p:P304
wds:Q35050505-D81B6BD7-8856-4F15-A2AE-CEACC16D42D2
wdt:P304
4074-4084
p:P31
wds:Q35050505-798EAE22-A3C4-426A-9665-39FAF3DA092A
wdt:P31
wd:Q13442814
p:P921
wds:Q35050505-1F21777D-BEC2-41E4-BE37-78260D0AA803 wds:Q35050505-A26A8CDA-B9CE-441F-810D-1661E09B0E7E
wdt:P921
wd:Q1427096 wd:Q79460
p:P698
wds:Q35050505-4360568F-C24B-4A89-9B4B-338A70A67C83
wdtn:P698
n8:21540234
wdt:P698
21540234
p:P1433
wds:Q35050505-366D1AC7-C9A7-45D8-ADFC-E169F29CF59B
wdt:P1433
wd:Q326097
p:P433
wds:Q35050505-9C4268A9-783F-4FB1-9700-76DB08A7FAAE
p:P478
wds:Q35050505-7A8F440E-7A17-4608-9636-DAC63BE987E3
wdt:P433
12
wdt:P478
71
p:P356
wds:Q35050505-396A288E-7EED-462D-B9DE-01B33ED1EACF
wdtn:P356
n12:0008-5472.CAN-10-3968
wdt:P356
10.1158/0008-5472.CAN-10-3968
p:P8608
wds:Q35050505-42950684-1C56-4CE1-B1AB-EED5D5FF8D80
wdt:P8608
release_4mjaltrolzhc3ochjdlu7p2j54
p:P932
wds:Q35050505-EEC4139B-6E51-4BBA-B008-F1EB897ACA55
wdt:P932
3116937